SAFETY AND EFFICACY IN MANAGING VAGINAL INFECTIONS
Not Applicable
- Conditions
- Health Condition 1: N761- Subacute and chronic vaginitis
- Registration Number
- CTRI/2022/01/039169
- Lead Sponsor
- Chettinad Hospital and Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All reproductive age women(18-39 years) with vaginal discharge and without any known gynaecological disorders.
Exclusion Criteria
Women with chronic inflammatory or autoimmune conditions
Women with poorly controlled Diabetes Mellitus
Women with sexually transmitted infections
Women currently on treatment with antimicrobials either topical or oral
Women on long term corticosteroids use
Women with contraceptives/ intrauterine devices
Pregnant women
Lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the effect of administering antimicrobials and probiotics in reproductive women with vaginal infectionTimepoint: Baseline, 2 weeks and 4 weeks
- Secondary Outcome Measures
Name Time Method To evaluate the reduction in the incidence of vaginal infectionsTimepoint: 2 weeks, 4 weeks